Camlin Fine Q1 FY27 results (Apr–Jun 2026) and concall

Chemicals · Concall AI · Call held 11 Aug 2026

Company page: Camlin Fine share price, financials & guidance record

Camlin Fine Sciences reported strong revenue growth of 28% YoY to ₹519.9 crores in Q1 FY27, driven by its Specialty Ingredients segment. However, profitability was severely impacted, with EBITDA margins compressing to 4% from 45% sequentially, primarily due to elevated raw material and freight costs. The Aroma segment posted a negative EBITDA due to low capacity utilization, while Performance Chemicals also saw subdued margins. The company anticipates margin recovery in subsequent quarters, targeting 10-11% EBITDA for FY27, as it passes on costs and ramps up production.

You’re reading a preview. Opening the full call uses 1 concall credit.

What they filed

Q1 FY27: revenue up 27.5%, net profit down 209.1% against the same quarter last year.

₹ Cr · quarterly

Line item	Q2 FY25	Q3 FY25	Q4 FY25	Q1 FY26	Q2 FY26	Q3 FY26	Q4 FY26	Q1 FY27
Revenue	417	431	432	408	460 +10%	441 +2%	425 −2%	520 +27%
Expenses	366	375	370	387	427	420	404	511
EBITDA	52	56	62	20	33 −37%	21 −62%	21 −66%	9 −55%
Margin	12%	13%	14%	5%	7%	5%	5%	2%
Other income	-151	-8	-22	0	-4	-24	103	-10
Interest	26	34	15	15	19	17	23	14
Depreciation	17	14	17	16	19	16	21	19
Profit before tax	-142	0	8	-11	-9 +94%	-37	80 +900%	-34 −209%
Tax rate	-18%	2164%	98%	0%	65%	0%	-8%	-1%
Net profit	-116	-7	0	-11	-15 +87%	-37 −429%	86	-34 −209%
EPS	-5.33	-0.22	-0.04	-0.53	-0.76	-1.89	4.59	-1.65

How to read this

₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.

Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.

What they filed

More Chemicals earnings calls